{"id":"NCT00643201","sponsor":"Bristol-Myers Squibb","briefTitle":"Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism","officialTitle":"A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-07","primaryCompletion":"2013-03","completion":"2013-03","firstPosted":"2008-03-26","resultsPosted":"2014-04-10","lastUpdate":"2014-04-21"},"enrollment":5614,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Venous Thrombosis"],"interventions":[{"type":"DRUG","name":"Enoxaparin","otherNames":[]},{"type":"DRUG","name":"warfarin","otherNames":["Coumadin","BMS-565793"]},{"type":"DRUG","name":"Placebo for apixaban","otherNames":[]},{"type":"DRUG","name":"Placebo for enoxaparin","otherNames":[]},{"type":"DRUG","name":"Placebo for warfarin","otherNames":[]},{"type":"DRUG","name":"apixaban","otherNames":["BMS-562247"]}],"arms":[{"label":"Apixaban","type":"ACTIVE_COMPARATOR"},{"label":"Enoxaparin + Warfarin","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the effects of an investigational blood thinner, apixaban, in preventing venous thromboembolic (VTE) recurrence or death in patients with deep vein thrombosis (DVT) or pulmonary embolism (PE)","primaryOutcome":{"measure":"Incidence of Adjudicated Composite of Symptomatic, Recurrent Venous Thromboembolism (VTE) or VTE-Related Death During 6 Months of Treatment","timeFrame":"Day 1 to Week 24 + 2 Days or 355 days (Discontinued Early)","effectByArm":[{"arm":"Apixaban","deltaMin":0.0226,"sd":null},{"arm":"Enoxaparin + Warfarin","deltaMin":0.0269,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"0.3128"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":381,"countries":["United States","Argentina","Australia","Austria","Brazil","Canada","Chile","China","Czechia","Denmark","France","Germany","Hong Kong","Hungary","India","Israel","Italy","Malaysia","Mexico","Norway","Poland","Portugal","Puerto Rico","Romania","Russia","Singapore","South Africa","South Korea","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["35570249","33890242","30650446","26627879","23808982"],"seeAlso":["http://www.bms.com/studyconnect/Pages/home.aspx","http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":417,"n":2676},"commonTop":["HEADACHE","PAIN IN EXTREMITY","EPISTAXIS","DIARRHOEA","OEDEMA PERIPHERAL"]}}